BlackRock Tech & Private Equity director reports sale of BTX shares
BlackRock Technology & Private Equity Term Trust reported share sales by one of its directors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BlackRock Technology & Private Equity Term Trust reported share sales by one of its directors. On 12/18/2025, the director sold 21,936 shares of common stock at a price of $6.52 per share. A further sale on 12/19/2025 is recorded at a price of $6.55 per share. After these transactions, the director reported owning 0 shares of the trust’s common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 0.7067 | $6.55 | $4.63 |
| Sale | Common Stock | 21,936 | $6.52 | $143K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BlackRock Technology & Private Equity Term Trust (BTX) disclose?
The trust disclosed that a director sold shares of its common stock, as reported in a Form 4 filing.
What is the relationship of the reporting person to BlackRock Technology & Private Equity Term Trust (BTX)?
The reporting person is identified as a director of BlackRock Technology & Private Equity Term Trust.
Is this BTX Form 4 filed for one or multiple reporting persons?
The filing indicates it is a Form filed by one reporting person, not a joint filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.